The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.

GREENFIELD — Sue Ann Wortman Cancer Center is doubling the size of its infusion center, where patients receive chemotherapy ...

Only it was still there when you went back to the dentist six months later. This time, there was a biopsy. It was cancer, the ...

Long before R.F.K., Jr., promised to “Make America Healthy Again,” wellness influencers were peddling a seductive promise of ...

For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (H ...

Mayo Clinic, Mount Sinai and Huntsman Cancer Insitute are delivering services from chemotherapy to imaging in cancer patients ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

Legendary Fox 8 News anchor Wayne Dawson shared an update with viewers while he was receiving chemotherapy at the Cleveland ...

by intravenous (IV) infusion every 3 weeks or investigator’s choice of chemotherapy (n=430; capecitabine 60%, nab-paclitaxel 24%, or paclitaxel 16%). The primary endpoint was progression free ...